BreastfeedingLAVENDER-SSCNCT07612059
Skin-to-Skin Contact and Lavender Aromatherapy After Elective Cesarean: Effects on Cortisol and Early Breastfeeding
A study testing Structured early postpartum mother-infant skin-to-skin contact and Maternal inhalational lavender aromatherapy in people with Breastfeeding and Cesarean Section, run by Ataturk University at 1 site in Turkey (Türkiye).
Trial summary
This single-center randomized controlled clinical trial will evaluate the effects of structured early postpartum mother-infant skin-to-skin contact, with or without maternal lavender aromatherapy, after elective cesarean section on maternal stress biomarkers and early breastfeeding outcomes. Read more about this study
- Who is it for?
- Ages 18 to 40 years, women onlyHealthy volunteers can take part
- Conditions the study is for
- Breastfeeding, Cesarean Section, Postpartum Period
- What is being tested?
- Structured early postpartum mother-infant skin-to-skin contact and Maternal inhalational lavender aromatherapy
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 150 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 1 Jun 2026to 30 Dec 2027
- Phase
- Interventional
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 40 years
- Women only
- Healthy volunteers accepted
- Adult
Who may be able to join
- Female participants aged 18 to 40 years
- Term singleton pregnancy (≥37 weeks of gestation)
- Scheduled for elective cesarean section
- ASA physical status I-II
- Planned spinal anesthesia
- Clinically stable mother and newborn immediately after birth
- Ability to initiate breastfeeding in the early postpartum period
- Provision of written informed consent
Who cannot join
- Emergency cesarean section
- General anesthesia or conversion from spinal to general anesthesia
- Need for neonatal resuscitation or severe neonatal compromise
- Maternal hemodynamic instability or massive hemorrhage
- Major fetal congenital anomalies
- Known allergy or intolerance to lavender
Show all 12Show fewer
- Severe asthma or intolerance to strong odors
- Major psychiatric disorders
- Serious endocrine diseases affecting stress hormone regulation
- Clinical conditions that preclude breastfeeding
- Contraindications to spinal anesthesia
- Refusal to participate in the study
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Turkey (Türkiye)1 site
Ataturk University
Erzurum, 25240
AYSENUR DOSTBİL, MD, +905333676696, adostbil@hotmail.com
orhan buyukkurt, MD, +905062883544, orti_jordan@hotmail.com
About this study
Official title: Elective Cesarean Section Postpartum Structured Mother-Infant Skin-to-Skin Contact With Maternal Lavender Aromatherapy: Effects on Maternal Salivary Cortisol, IgA Levels and Early Breastfeeding Outcomes - A Randomized Controlled Trial
This single-center randomized controlled clinical trial will evaluate the effects of structured early postpartum mother-infant skin-to-skin contact, with or without maternal lavender aromatherapy, after elective cesarean section on maternal stress biomarkers and early breastfeeding outcomes. The study will enroll 150 term pregnant women scheduled for elective cesarean section under spinal anesthesia at Ataturk University Research Hospital. Participants will be randomized into three groups: routine postoperative care, structured skin-to-skin contact, and structured skin-to-skin contact combined with inhalational lavender aromatherapy. The primary outcome is the change in maternal salivary cortisol level from immediately after birth to 60 minutes postpartum. Secondary outcomes include maternal salivary IgA levels, state anxiety scores, postoperative pain and nausea, time to first analgesic requirement, early breastfeeding initiation and success, LATCH scores, neonatal axillary temperature, cumulative duration and continuity of skin-to-skin contact, maternal satisfaction, and the need for mother-infant separation within the first 2 hours postpartum.
Read the detailed description
Cesarean section rates are increasing worldwide, and optimizing maternal and neonatal outcomes in the early postpartum period has become a clinical priority. Elective cesarean delivery is associated with surgical and anesthetic stress, altered hypothalamic-pituitary-adrenal axis activation, and delayed mother-infant interaction, which may negatively affect bonding and breastfeeding. Early skin-to-skin contact between mother and newborn is an evidence-based physiological intervention that promotes thermal stability, attenuates stress responses, and supports breastfeeding, but its hormonal and biochemical mechanisms after elective cesarean section have not been fully elucidated. Lavender aromatherapy is a non-pharmacological method that has been reported to reduce perioperative anxiety and pain in cesarean mothers; however, its combined use with structured skin-to-skin contact in the early postpartum period has not been previously investigated in a randomized controlled design.
This prospective, randomized, controlled, three-arm interventional study will be conducted in the Obstetrics and Gynecology Clinic of Ataturk University Faculty of Medicine Research Hospital. A total of 150 volunteer pregnant women aged 18-40 years with term singleton pregnancies scheduled for elective cesarean section under spinal anesthesia and classified as ASA physical status I-II will be included. Participants will be randomized in equal numbers (n=50 per group) to: Group 1, routine postoperative care; Group 2, structured early postpartum mother-infant skin-to-skin contact; and Group 3, structured skin-to-skin contact plus maternal inhalational lavender aromatherapy. All interventions will be delivered by anesthesiology investigators trained in the study protocol. Salivary samples for cortisol and IgA will be collected immediately after birth (T0) and at 60 minutes postpartum (T1). State anxiety (STAIS-5), postoperative pain (VAS), nausea-vomiting, time to first analgesic requirement, breastfeeding initiation time, breastfeeding success within the first 60 and 120 minutes, LATCH scores, neonatal axillary temperature, cumulative duration and interruptions of skin-to-skin contact, the need for mother-infant separation, and maternal satisfaction at 120 minutes (T2) will be systematically recorded using predefined case report forms.
Routine intraoperative and postoperative monitoring and care will be maintained for all participants, and no additional invasive procedures or pharmacological agents beyond standard practice will be introduced. Statistical analyses will be performed using IBM SPSS Statistics v26.0. Continuous variables will be summarized as mean and standard deviation or median and interquartile range as appropriate, and categorical variables as counts and percentages. Between-group comparisons will use one-way ANOVA or Kruskal-Wallis tests for continuous variables and chi-square or Fisher's exact tests for categorical variables. Changes in cortisol over time will be analyzed with repeated-measures methods, and the relationship between cumulative skin-to-skin duration and cortisol change will be assessed using Pearson or Spearman correlation coefficients. All comparisons will be reported with 95 confidence intervals, with a two-sided p value less than 0.05 considered statistically significant.
- Conditions
- Breastfeeding, Cesarean Section, Postpartum Period, Maternal Stress
- Being tested
- Structured early postpartum mother-infant skin-to-skin contact, Maternal inhalational lavender aromatherapy
- Keywords
- Elective cesarean section, Skin-to-skin contact, Lavender aromatherapy, Salivary cortisol, Immunoglobulin A (IgA), Early breastfeeding, Postoperative pain
- Medical subject headings
- Breast Feeding, Pain, Postoperative
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Structured early postpartum mother-infant skin-to-skin contactBehavioural
A structured early postpartum skin-to-skin contact protocol applied after elective cesarean section under spinal anesthesia. Following stabilization of the mother and newborn, the naked neonate is placed prone on the mother's bare chest and covered with a warm blanket. Continuous skin-to-skin contact is maintained during the first 60 minutes postpartum as tolerated, and cumulative duration, number of interruptions, and reasons for interruption are recorded.
Maternal inhalational lavender aromatherapyOther
Maternal inhalational aromatherapy using lavender essential oil during the early postpartum period after elective cesarean section. Lavender oil is applied via inhalation using a cotton pad or similar carrier placed near the mother's face during the first 60 minutes postpartum, in combination with the structured skin-to-skin contact protocol, as tolerated. Tolerance to aromatherapy and any adverse reactions are monitored and recorded.
| Study group | Role | What they receive |
|---|---|---|
| Routine Care | No intervention | Participants in this arm will receive routine intraoperative and postoperative care after elective cesarean section under spinal anesthesia, according to the standard practice of Ataturk University Research Hospital. No structured early skin-to-skin contact protocol or lavender aromatherapy will be applied beyond usual care. |
| Structured Skin-to-Skin Contact | Experimental | Participants in this arm will receive a structured early postpartum mother-infant skin-to-skin contact protocol after elective cesarean section under spinal anesthesia. Following delivery and clinical stabilization of the mother and newborn, the naked neonate will be placed prone on the mother's bare chest, covered with a warm blanket, and maintained in continuous skin-to-skin contact during the first 60 minutes postpartum as tolerated. Cumulative duration of skin-to-skin contact, number of interruptions, and reasons for interruption will be recorded. Receives: Behavioral: Structured early postpartum mother-infant skin-to-skin contact |
| Structured Skin-to-Skin Contact Plus Lavender Aromatherapy | Experimental | Participants in this arm will receive the same structured early postpartum mother-infant skin-to-skin contact protocol as in the skin-to-skin only group, combined with maternal inhalational lavender aromatherapy. Lavender essential oil will be administered via inhalation using a cotton pad or similar carrier placed near the mother's face during the early postpartum period, starting shortly after surgery and maintained during the first 60 minutes postpartum as tolerated, according to the study protocol. Tolerance to aromatherapy and any adverse reactions will be monitored and recorded. Receives: Behavioral: Structured early postpartum mother-infant skin-to-skin contact; Other: Maternal inhalational lavender aromatherapy |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change in maternal salivary cortisol level
Difference in maternal salivary cortisol concentration between immediately after birth (T0) and 60 minutes postpartum (T1), compared among the three study groups.
Measured: From immediately after birth (T0) to 60 minutes postpartum (T1)
Secondary outcomes (11)
Maternal salivary IgA level
Maternal salivary immunoglobulin A (IgA) concentrations measured immediately after birth (T0) and at 60 minutes postpartum (T1), compared among study groups.
Measured: From immediately after birth (T0) to 60 minutes postpartum (T1)
State anxiety score (STAIS-5)
Change in maternal state anxiety assessed using the 5-item State-Trait Anxiety Inventory short form (STAIS-5) at preoperative baseline, 60 minutes (T1), and 120 minutes (T2) postpartum.
Measured: Preoperative baseline to 120 minutes postpartum (T2)
Postoperative pain intensity (VAS)
Maternal postoperative pain scores measured using a 0-10 cm visual analog scale (VAS) at 60 minutes (T1) and 120 minutes (T2) postpartum.
Measured: 60 minutes (T1) and 120 minutes (T2) postpartum
Postoperative nausea and vomiting
Presence and severity of postoperative nausea (0-3 scale) and the occurrence of vomiting recorded at 60 minutes (T1) and 120 minutes (T2) postpartum.
Measured: 60 minutes (T1) and 120 minutes (T2) postpartum
Time to first analgesic requirement
Time from completion of surgery to first request or administration of postoperative analgesia, recorded in minutes.
Measured: From end of surgery to first analgesic requirement within the first 24 hours postoperatively
Early breastfeeding success
Proportion of mothers achieving successful breastfeeding within the first 60 and 120 minutes postpartum, as judged by effective latch and sustained feeding.
Measured: Within 60 minutes and within 120 minutes postpartum
LATCH breastfeeding score
Breastfeeding performance assessed using the LATCH scoring system (total score 0-10) during the first successful breastfeeding attempt and, if needed, repeated at 120 minutes postpartum (T2).
Measured: From first breastfeeding attempt up to 120 minutes postpartum (T2)
Neonatal axillary temperature
Neonatal axillary temperature measured with a digital thermometer at 60 minutes (T1) and 120 minutes (T2) postpartum.
Measured: 60 minutes (T1) and 120 minutes (T2) postpartum
Cumulative duration of skin-to-skin contact
Total cumulative duration (in minutes) of mother-infant skin-to-skin contact during the first 60 and 120 minutes postpartum, including number and reasons for interruptions.
Measured: From birth to 60 minutes and to 120 minutes postpartum
Need for mother-infant separation
Requirement for temporary separation of mother and infant for clinical reasons during the first 2 hours postpartum (yes/no).
Measured: Within the first 120 minutes postpartum
Correlation between skin-to-skin duration and cortisol change
Correlation between cumulative duration of skin-to-skin contact and change in maternal salivary cortisol level from T0 to T1.
Measured: From immediately after birth (T0) to 60 minutes postpartum (T1)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted28 May 2026
- Study start1 Jun 2026 (estimated)
- Primary completion1 Jun 2026 (estimated)
- Study completion30 Dec 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (3)Papers the sponsor has linked to this study.
- Other trials for BreastfeedingStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Parallel assignment of three groups: routine postoperative care, structured early postpartum mother-infant skin-to-skin contact, and structured skin-to-skin contact combined with maternal inhalational lavender aromatherapy after elective cesarean section under spinal anesthesia.
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 150 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Ataturk University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Aysenur Dostbil, Ataturk University
- Investigators
- kamber kasali, PhD, Study chair, Atatürk University Faculty of Medicine, Department of Biostatistics, Erzurum, Turkeygamzenur cimilli senocak, MD, Study chair, Atatürk University Faculty of Medicine, Department of Obstetrics and Gynecology, Erzurum, Turkeyorhan buyukkurt, MD, Study chair, Ataturk University Faculty of Medicine, Department of Anesthesiology and Reanimation
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07612059
- Sponsor's protocol ID
- B.30.2.ATA.0.01.00/229
- Acronym
- LAVENDER-SSC
- Status last verified
- May 2026
- First submitted
- 21 May 2026
- Last updated
- 28 May 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: There is no current plan to share individual participant data (IPD) outside the study team due to institutional and national data protection regulations.
Publications
Namba Y, Smith JB, Fox GS, Challis JR. Plasma cortisol concentrations during Caesarean section. Br J Anaesth. 1980 Oct;52(10):1027-32. doi: 10.1093/bja/52.10.1027.
PubMed 7437211Nouira M, Souayeh N, Kanzari SA, Rouis H, Lika A, Mbarki C, Rahali FZ, Bettaieb H. Aromatherapy Using Lavender Oil Effectiveness on Pain and Anxiety After C-Section: A Randomized Controlled Trial. J Epidemiol Glob Health. 2024 Dec;14(4):1536-1544. doi: 10.1007/s44197-024-00305-6. Epub 2024 Oct 14.
PubMed 39400653Widstrom AM, Brimdyr K, Svensson K, Cadwell K, Nissen E. Skin-to-skin contact the first hour after birth, underlying implications and clinical practice. Acta Paediatr. 2019 Jul;108(7):1192-1204. doi: 10.1111/apa.14754. Epub 2019 Mar 13.
PubMed 30762247